Growth Investing in Indian Markets: Real Examples and Numbers

What Growth Investing Actually Means

Growth investing is a strategy that targets companies expected to grow earnings and revenue at an above average rate compared with the overall market. Instead of returning cash to shareholders as dividends, these companies reinvest profits into new capacity, research, stores, technology and acquisitions. The investor is paid through capital appreciation, meaning the share price rises as the business gets bigger, rather than through a regular dividend cheque.

In Indian markets that usually means buying companies listed on the National Stock Exchange (NSE) or BSE that are gaining market share in a fast expanding category. Think of a retailer adding stores every quarter, an electronics manufacturer winning new contracts under government incentive schemes, or a financier whose loan book is compounding at 25 percent a year. The bet is simple to state and hard to execute. You are paying a premium today on the belief that profits two and three years out will be much larger.

The opposite school is value investing, which hunts for companies trading below their intrinsic value with a margin of safety. Growth investors deliberately accept a higher price tag because they expect the earnings denominator to grow into that price. Both can work. The difference is what you are paying for and what has to go right for you to be rewarded.

Real Recent Growth Numbers for Named Indian Stocks

Generic examples like "imagine EPS rises from Rs 5 to Rs 8" teach nothing about the Indian market. Here are actual reported figures from recent annual results so you can see what real growth and real slowdown look like side by side. These are historical consolidated numbers and are illustrative for learning, not a recommendation to buy or sell.

Read that table carefully. Trent and Dixon are genuine growth stories where the top line jumped roughly 49 percent and 44 percent in a single year. TCS and Infosys, often described loosely as growth stocks, actually grew revenue in the mid single digits in FY24 as global IT spending slowed. That gap is the whole point. A name can be high quality and still not be in a high growth phase. Always check the latest reported numbers rather than relying on a reputation built years ago.

The Metrics That Separate Real Growth From a Story

Growth investing lives and dies on a handful of numbers. The headline figure is earnings per share (EPS) growth, which tells you how fast profit per share is rising. Revenue growth tells you whether the business is genuinely selling more, while return on equity (ROE) tells you how efficiently the company turns shareholder money into profit. A firm growing revenue 40 percent a year but with ROE stuck in single digits is buying that growth expensively.

A grounded way to use these numbers is the PEG ratio, which divides the price to earnings multiple by the earnings growth rate. Suppose a stock trades at a price to earnings of 60 and is genuinely compounding earnings at 30 percent a year. Its PEG is 60 divided by 30, which equals 2.0. A PEG well above 1 means you are paying up heavily for the growth, so any slowdown can punish the share price. PEG is a rough guide, not a law, but it stops you from confusing a fast grower with a sensibly priced one.

• EPS growth: is profit per share rising at 20 percent or more per year on a consistent basis.
• Revenue growth: is the top line genuinely expanding, not just margins flattering one quarter.
• Return on equity (ROE): above 15 to 18 percent suggests the growth is efficient and not just debt fuelled.
• Debt to equity: heavy borrowing to fund growth raises risk if demand stalls or rates rise.
• PEG ratio: price to earnings divided by growth rate, a quick check on whether you are overpaying.

A Fully Worked Cash Equity Example With Indian Taxes

Numbers make this concrete. Suppose in early FY25 you buy 200 shares of Trent at Rs 4,500 each, after the stock re rated on the back of that roughly 49 percent FY24 revenue jump. Your outlay is 200 multiplied by Rs 4,500, which is Rs 9,00,000. Assume that 14 months later the price has risen to Rs 5,800 as the growth thesis holds. These prices are illustrative, chosen to show the mechanics, not a forecast.

Your sale value is 200 multiplied by Rs 5,800, which is Rs 11,60,000. The gross gain is Rs 11,60,000 minus Rs 9,00,000, which is Rs 2,60,000. On delivery equity, securities transaction tax (STT) is 0.1 percent on both buy and sell. STT on the buy is about Rs 900 and on the sell about Rs 1,160, so roughly Rs 2,060 of STT, plus a few hundred rupees of exchange and SEBI charges, GST on brokerage and stamp duty. Discount brokers often charge zero brokerage on delivery, so total costs here are modest, call it about Rs 2,500 all in for illustration.

Because you held for more than 12 months, this is a long term capital gain (LTCG). Under the current rule, LTCG on listed equity is exempt up to Rs 1.25 lakh per financial year and taxed at 12.5 percent above that. Your gain of about Rs 2,57,500 net of costs, minus the Rs 1,25,000 exemption, leaves Rs 1,32,500 taxable. The tax is 12.5 percent of Rs 1,32,500, which is about Rs 16,563. Your net profit after costs and tax is roughly Rs 2,57,500 minus Rs 16,563, which is about Rs 2,40,937.

Where Derivatives Fit, and Where They Do Not

Growth investing is fundamentally a cash equity and delivery game because the payoff takes quarters and years to play out. Futures and options are leveraged and time bound, so they are a poor home for a multi year growth thesis. That said, traders sometimes use index derivatives to hedge a growth heavy portfolio around events like budgets or results season. If you do, the contract specifications matter.

Take a concrete Nifty hedge. Suppose Nifty is near 24,000 and you buy one weekly 24,000 put at a premium of Rs 120 to protect gains. The Nifty lot size is 65, so one contract controls 75 multiplied by 24,000, which is Rs 18,00,000 of notional exposure. Your cost is 75 multiplied by Rs 120, which is Rs 9,000 plus charges. If Nifty falls to 23,600 at expiry, the put is worth 400 points, so 75 multiplied by Rs 400 equals Rs 30,000, a gross gain of Rs 21,000 before STT and brokerage. If the market instead rises, your put expires worthless and you lose the Rs 9,000 premium, which is the cost of the insurance.

• Nifty weekly and monthly options expire on Tuesday under the current NSE schedule, while monthly stock F&O expires on the last Tuesday.
• Lot sizes to remember: Nifty 75, Bank Nifty 15, FinNifty 25, Sensex 10.
• Profit or loss on F&O is treated as business income in India and taxed at your slab rate, not at the 12.5 percent LTCG rate.
• Options lose value as expiry approaches due to time decay, which is why they suit short hedges, not long term growth bets.

Note the tax difference clearly. Your delivery Trent profit was taxed as a capital gain. If you traded that Nifty option, the result would be business income taxed at your income tax slab, and it would need to be reported accordingly. Mixing the two without understanding the tax treatment is a common and expensive mistake.

The Valuation Trap That Catches Most Beginners

The single biggest risk in growth investing is overpaying for growth that is already priced in. When a stock like Trent trades above a 150 times trailing price to earnings multiple, the market is already assuming many years of rapid expansion. If the company grows fast, you may still do well. If growth merely slows from 45 percent to 25 percent, which is still excellent in absolute terms, the share price can fall hard because expectations were set even higher.

This is why the same business can be a brilliant company and a poor investment at the wrong price. A useful discipline is to ask what growth rate the current valuation implies, then judge whether that is realistic. If a stock at a price to earnings of 80 needs 40 percent annual earnings growth for a decade to justify the price, history says very few companies sustain that. Pricing in perfection leaves no room for the normal stumbles every business has.

Sectors Driving Indian Growth Right Now

Growth tends to cluster in sectors riding a structural tailwind. In India the most visible recent ones are electronics manufacturing supported by the Production Linked Incentive (PLI) scheme, which lifted firms like Dixon Technologies, and value retail, where Trent's Zudio format expanded store count rapidly. Other areas include capital goods and defence on the back of higher government capex, and renewable energy as India targets large additions to clean power capacity.

Contrast that with information technology services. Infosys and TCS are excellent, cash rich businesses, but in FY24 they grew revenue in the mid single digits as global clients cut discretionary spending. They behaved more like steady compounders than high growth stocks during that period. The lesson is to follow where the actual growth is showing up in the numbers, sector by sector, rather than assuming a label that was earned in an earlier cycle.

• Electronics and EMS: Dixon Technologies and peers benefiting from PLI and import substitution.
• Value and quick service retail: Trent, Zudio and similar fast store rollouts.
• Capital goods and defence: order book growth driven by government and private capex.
• Renewable energy and power: capacity additions tied to India's clean energy targets.
• Consumer and beverages: steady high teens to low twenties growth from names like Varun Beverages.

Growth Investing Versus Value Investing

These two styles answer different questions. Growth investing asks how big this company can become, and accepts a high price today for a bigger business tomorrow. Value investing asks whether the market has mispriced this company below its worth, and demands a discount as a cushion. Neither is universally superior. They tend to take turns leading depending on interest rates and the economic cycle, with growth often favoured when rates are low and value when rates are high.

Common Mistakes and How to Avoid Them

The first mistake is overpaying for growth, covered above. The second is failing to re check the thesis. Growth stories change. A retailer's same store sales can slow, a manufacturer can lose a key contract, or a regulatory shift can compress margins. If you bought because revenue was compounding at 40 percent, you must sell or rethink when that rate drops materially and the price still assumes the old pace.

A third mistake is ignoring concentration risk. A portfolio of five high valuation growth names can fall together in a market correction because they share the same sensitivity to interest rates and sentiment. Position sizing and some diversification across sectors reduce the chance that one bad quarter wipes out a year of gains. The point is not to avoid growth, but to size it so a single disappointment does not break the portfolio.

• Do not buy purely on a high past growth rate without checking the current valuation and PEG.
• Re read the latest quarterly results and management commentary at least every quarter.
• Watch debt levels, since growth funded by heavy borrowing is fragile if demand or rates turn.
• Avoid over concentration in a handful of similar high multiple names.
• Keep a clear exit rule for when the growth thesis is broken, not just when the price drops.

Sources and Further Reading

Revenue and profit figures above are drawn from company annual results and should be verified against the latest filings. For authoritative data and further reading, refer to Zerodha Varsity, Investopedia, NSE India and SEBI. Always confirm current rules, tax rates and contract specifications on the official source before you trade or invest.

Sources and Further Reading

For authoritative data and further reading on this topic, refer to Zerodha Varsity, Investopedia, NSE India and AMFI. Always confirm current rules, rates and contract specifications on the official source before you trade.